Company / Current Liabilities per Share
Caribou Biosciences, Inc. Current Liabilities per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.28
FY2025
5-year range
$0.28 / $2.66
FY2021-FY2025
Trend
-20.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has declined for 4 consecutive years, from $2.66 in FY2021 to $0.28 in FY2025.
Based on SEC 10-K filings.
0.28 in FY2025 with a 3-year CAGR of -16.2%.
Improved from $0.46 to $0.28 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -16.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Caribou Biosciences, Inc.'s current liabilities per share has declined for 4 consecutive years.
- In FY2025, current liabilities per share decreased 20.6% year-over-year.
- Peak current liabilities per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.28 | -20.6% |
| FY2024 | $0.35 | -25.3% |
| FY2023 | $0.46 | -0.6% |
| FY2022 | $0.47 | -82.5% |
| FY2021 | $2.66 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026